يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Friedrich Overkamp"', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

    المؤلفون: Hanna Huebner, Christian M. Kurbacher, Geoffrey Kuesters, Andreas D. Hartkopf, Michael P. Lux, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans Tesch, Lothar Häberle, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Matthias Ruebner, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja N. Fehm, Hans-Christian Kolberg, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Johannes Ettl

    المصدر: BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)

    مصطلحات موضوعية: Advanced breast cancer, Metastatic, Antihormone therapy, Heregulin, Seribantumab, MM-121, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12885-020-07546-1Test; https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/3595f6bd2f1948ae89b5ca12ff495d0fTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

    المؤلفون: Thomas Decker, Friedrich Overkamp, Siegfried Rösel, Arnd Nusch, Thomas Göhler, Martin Indorf, Jörg Sahlmann, Tanja Trarbach

    المصدر: BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)

    مصطلحات موضوعية: Metastatic breast cancer, Paclitaxel, Sorafenib, Antineoplastic agents/chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12885-017-3492-1Test; https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/9dda1d8dbdb949749cf242d7ff131707Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial

    المؤلفون: Wolf O. Bechstein, Friedrich Overkamp, Victoria Smith-Machnow, Matthias Vöhringer, Michael P. Schön, Michael Heike, Richard Greil, Eric Van Cutsem, Peter R. Galle, Daniel Seehofer, Stefan Kasper, Jan Schröder, Markus Möhler, Bernhard Linz, Ines Gockel, Götz Peter Lothar von Wichert, Susanna Hegewisch-Becker, Frank Kullmann, Volker Heinemann, Irene Schmidtmann, Marc Peeters, Hauke Lang, Carl C. Schimanski, Stephan Kanzler

    المصدر: BMC Cancer, Vol 12, Iss 1, p 144 (2012)
    BMC Cancer
    BMC cancer

    مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Cancer Research, Colorectal cancer, Medizin, Adenocarcinoma, Placebo, Cancer Vaccines, lcsh:RC254-282, law.invention, Study Protocol, Double-Blind Method, Randomized controlled trial, Surgical oncology, law, Internal medicine, medicine, Genetics, Humans, ddc:610, Survival analysis, Neoplasm Staging, Membrane Glycoproteins, business.industry, Liver Neoplasms, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, Survival Analysis, Clinical trial, Tolerability, Female, Human medicine, Neoplasm Recurrence, Local, Colorectal Neoplasms, business

    وصف الملف: application/octet-stream; pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03316a77d80f229ef8ad319b0aa3b2e3Test
    http://www.biomedcentral.com/1471-2407/12/144Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث